Protagonist Therapeutics Free Cash Flow (Quarterly) Analysis

Protagonist Therapeutics Inc (PTGX)

40.60 -0.44 (-1.07%) USD | NASDAQ | Nov 15, 12:45

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
September 30, 2024	-28.64M
June 30, 2024	268.59M
March 31, 2024	-27.67M
December 31, 2023	16.94M
September 30, 2023	-27.02M
June 30, 2023	-26.41M
March 31, 2023	-34.36M
December 31, 2022	-31.70M
September 30, 2022	-25.36M
June 30, 2022	-13.92M
March 31, 2022	-37.94M
December 31, 2021	-27.14M
September 30, 2021	-28.74M
June 30, 2021	-24.20M
March 31, 2021	-28.90M
December 31, 2020	-18.99M
September 30, 2020	-16.36M
June 30, 2020	-21.62M
March 31, 2020	-15.99M
December 31, 2019	-14.51M

Date	Value
September 30, 2019	-13.94M
June 30, 2019	2.778M
March 31, 2019	-16.83M
December 31, 2018	-10.20M
September 30, 2018	-9.424M
June 30, 2018	-15.47M
March 31, 2018	-15.35M
December 31, 2017	-14.20M
September 30, 2017	40.51M
June 30, 2017	-12.70M
March 31, 2017	-10.40M
December 31, 2016	-9.732M
September 30, 2016	-6.996M
June 30, 2016	-8.101M
March 31, 2016	-5.49M
December 31, 2015	-4.959M
September 30, 2015	-3.882M
June 30, 2015	-3.505M
March 31, 2015	-2.438M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-37.94M

Minimum

Mar 2022

268.59M

Maximum

Jun 2024

-8.196M

Average

-25.89M

Median

Free Cash Flow (Quarterly) Benchmarks